Literature DB >> 8784138

Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

L Belayev1, O F Alonso, R Busto, W Zhao, M D Ginsberg.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of the present study was to evaluate a modified method of intraluminal suture occlusion of the middle cerebral artery (MCA) on the volume of brain infarction and on neurobehavioral function in rats subjected to a temporary focal ischemic insult.
METHODS: Male Sprague-Dawley rats were anesthetized with halothane and subjected to 60 minutes or 2 hours of temporary MCA occlusion (MCAo) by an intraluminal thread. In one group of rats, the suture was coated with poly-L-lysine, while in a second group, a conventional uncoated suture was used. Behavioral function was evaluated at 50 to 60 minutes after occlusion and during a 3-day period after MCAo. Three days after MCAo brains were perfusion-fixed and infarct volumes were measured.
RESULTS: In rats with 60-minute MCAo, only 3 of 7 animals with uncoated sutures had infarcts, whereas in the group with poly-L-lysine-coated sutures, all rats (n = 7) exhibited infarction (P = .009, Fisher's exact test). With 2 hours of MCAo, total infarct volume (corrected for brain edema) was significantly larger in rats with poly-L-lysine-coated sutures than in the group with uncoated sutures (mean +/- SEM, 122.1 +/- 4.8 versus 67.0 +/- 18.2 mm3, respectively; P = .03; n = 4 in each group). In the 2-hour MCAo study, infarct volumes in the uncoated-suture group tended to be variable and inconsistent (coefficient of variation, 54%) compared with the group in which sutures were coated with poly-L-lysine, in which a highly consistent infarct was produced (coefficient of variation of infarct volume, 8%).
CONCLUSIONS: Reversible MCAo in which a poly-L-lysine-coated intraluminal suture was used proved to be a reliable and effective modification of this technique, yielding consistently larger infarcts and greatly reduced interanimal variability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784138     DOI: 10.1161/01.str.27.9.1616

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  213 in total

Review 1.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  The search for neuroprotective strategies in stroke.

Authors:  Gary H Danton; W Dalton Dietrich
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

3.  The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia-reperfusion injury in rats.

Authors:  Sheng Peng; Zhongshen Kuang; Yan Zhang; Hang Xu; Qinghong Cheng
Journal:  Mol Biol Rep       Date:  2010-05-16       Impact factor: 2.316

4.  Association between changes in weight and cerebral arteries in rats.

Authors:  Afshin A Divani; Ankur Patel; Vance L Fredrickson; Blake Siljander; Gabriela Vazquez
Journal:  Transl Stroke Res       Date:  2010-03-02       Impact factor: 6.829

5.  LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.

Authors:  Ludmila Belayev; Larissa Khoutorova; Kristal Atkins; Alice Cherqui; Julio Alvarez-Builla; Nicolas G Bazan
Journal:  Brain Res       Date:  2008-12-03       Impact factor: 3.252

6.  Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Leila Aminova; Brett Langley; Stephen McConoughey; Ksenia Karpisheva; Hsin-Hwa Lee; Thomas Carmichael; Harley Kornblum; Giovanni Coppola; Daniel H Geschwind; Ahmet Hoke; Natalya Smirnova; Cameron Rink; Sashwati Roy; Chandan Sen; Michael S Beattie; Ron P Hart; Martin Grumet; Dongming Sun; Robert S Freeman; Gregg L Semenza; Irina Gazaryan
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 7.  A novel mouse model of thromboembolic stroke.

Authors:  Yingxin Chen; Wenbin Zhu; Wenri Zhang; Nicole Libal; Stephanie J Murphy; Halina Offner; Nabil J Alkayed
Journal:  J Neurosci Methods       Date:  2015-09-18       Impact factor: 2.390

Review 8.  Improving the translation of animal ischemic stroke studies to humans.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Metab Brain Dis       Date:  2014-02-15       Impact factor: 3.584

9.  Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.

Authors:  Sung-Ha Hong; Ludmila Belayev; Larissa Khoutorova; Andre Obenaus; Nicolas G Bazan
Journal:  J Neurol Sci       Date:  2013-12-31       Impact factor: 3.181

10.  Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.

Authors:  Wenfang Lai; Zhenwei Zheng; Xiaoqin Zhang; Yicong Wei; Kedan Chu; John Brown; Guizhu Hong; Lidian Chen
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.